Data is a pharmaceutical company’s biggest asset. A recent report by Ovum has highlighted that IT spending in the small pharma/biotech sector will total $10.5bn in 2017. Investing in technology which allows firms to collect, manage and analyze vast amounts of data from numerous sources is an investment that can only pay off. We live [...]
↧